Phase 4 N=60 Management of Sub-Clinical Bacteriuria in Pregnancy
Cystitis · Cystitis;Puerperium · Pyelonephritis
Primary: Number of Participants Who Have Cystitis — 4; 4 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=110 Restricted Reporting for Positive Urine Cultures
Bacteriuria · Urinary Tract Infection
Primary: The Number of Patients Receiving Appropriate Treatment — 44; 29 Participants
N/A N=100 Modified Reporting of Positive Urine Cultures Collected From Long Term Care
Urinary Tract Infections · Asymptomatic Bacteriuria
Primary: Proportion of Asymptomatic Bacteriuria Treated With Antibiotics and Urinary Tract Infection Treated With Antibiotics — 31; 25 Participants
N/A N=1,598 Asymptomatic Bacteriuria Guideline Implementation Study
Infection Due to Indwelling Urinary Catheter · Asymptomatic Bacteriuria
Primary: Number of Cases of ABU That Are Treated Inappropriately With Antibiotics — 1.6; 0.6; 0.5; 0.6 cases/1,000 bed-days
N/A N=139 Evaluating the Effect of the Probiotic on Recurrent Urinary Tract Infection in Adult Women
Recurrent Urinary Tract Infection in Adult Women
Primary: To Evaluate the Effect of Oral Supplementation With Lactobacillus Reuteri on the Frequency of Confirmed UTI in Adult Women With Recurrent UTI. — 1.2; 1.3 Number of…
N/A N=20 Reduction of Bacteriuria in Subjects Practicing Intermittent Catheterization
Bacteriuria
Primary: Total Bacteria Count Change From Baseline and After 24 Hours. — -62519; 57448 CFU/mL — p=0.6250
Phase 1 N=10 Bacterial Interference for Prevention of Catheter-Associated UTI: Geriatric Pilot Study
Urinary Tract Infection
Primary: Rate of UTI While Colonized With E. Coli 83972. — 8.5 UTIs per 1000 patient-days
Phase 2 N=134 Bacterial Genomic Sequencing in Overactive Bladder
Overactive Bladder
Primary: Bacterial Genomic Sequencing — 25; 11; 3; 6 participants
Phase 3 N=185 A Trial of Cranberry Capsules for Urinary Tract Infection Prevention in Nursing Home Residents
Bacteriuria
Primary: Participants With Urine Cultures With Bacteriuria (>100,000 Cfu/ml or >=100,000 Cfu/ml) Plus Pyuria (Any WBC) — 26; 32; 21; 27 participants
Phase 4 N=250 Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)
UTI - Lower Urinary Tract Infection · Antibiotic Resistant Infection
Primary: Number of Subjects With Combined Clinical and Microbiologic Response — 70 Participants
N/A N=27 Effectiveness of Cranberry Ingestion on Bacterial Adhesion: An Adjunct Study
Asymptomatic Bacteriuria
Primary: Antimicrobial Activity of Urine From Pregnant Subjects Following Cranberry Juice Cocktail (CJC) — 117.5; 105.0; 110.0 cfu per ml
N/A N=100 Modified Reporting From Indwelling Catheters
Urinary Tract Infections
Primary: Number of Participants With Appropriate Treatment — 31; 23 Participants — p=0.45
N/A N=200 Urinalysis Results in Healthy Individuals
Asymptomatic Bacteriuria · Asymptomatic Pyuria
Primary: False Positive Urine — 6; 40 Participants
Phase 4 N=57 Effects of Antibiotic Prophylaxis on Recurrent UTI in Children
Urinary Tract Infection · Recurrent Urinary Tract Infection
Primary: Changes to the Urinary Microbiota — 3; 2; 1 participants
Phase 1 N=36 Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli
Urinary Tract Infections
Primary: Number of Participants With Treatment-related Adverse Events as Assessed by DAIDS v2.1 — 0; 0 Participants
Phase 2 N=370 Gentamicin Intravesical Efficacy for Infection of Urinary Tract
Postoperative Urinary Tract Infection · Pelvic Organ Prolapse · Stress Urinary Incontinence
Primary: Post-operative Urinary Tract Infection — 19; 20 Participants
Phase 3 N=27 Lactobacillus Probiotic for Prevention of UTI
Urinary Tract Infections (UTI's)
Primary: UTI Incidence as Described Below, Over the 16 Week Study Period Following Randomization, in the LACTIN-V Treatment Group (Group A) as Compared to the Placebo Group…
Phase 4 N=154 Nitrofurantoin Prophylaxis During Catheter-managed Acute Urinary Retention After Pelvic Reconstructive Surgery
Pelvic Organ Prolapse
Primary: Number of Participants Experiencing Urinary Tract Infection Within 6 Weeks of Surgery — 13; 13 Participants — p=0.97
Phase 1 N=140 Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections
Uncomplicated Urinary Tract Infections · Urinary Tract Infections
Primary: Number of Participants With Microbiological Response at the Test of Cure (ToC) Visit — 10; 10; 1; 18 Participants
N/A N=338 A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection
Urinary Tract Infections · Bladder, Neurogenic
Primary: Clinical Validation of Biosensor Assays Used for Pathogen Identification and Antimicrobial Susceptibility Testing in Patients at Risk of Urinary Tract Infections. — 89…
Phase 1 N=13 Colonizing Neurogenic Bladders With Benign Flora
Spinal Cord Injury · Urinary Tract Infection
Primary: Bladder Colonization — 62 percentage of participants
N/A N=300 Single Dose Monurol for Treatment of Acute Cystitis
Urinary Tract Infection
Primary: Number of Participants Who Were Cured — 120; 130 Participants — p=<0.001
Phase 3 N=1,671 Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women
Uncomplicated Urinary Tract Infections
Primary: Percentage of Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants With Overall Success — 62.6; 36.0 percentage of participants
N/A N=60 Urinary Cytokines in Patients With Overactive Bladder (OAB)
Overactive Bladder · Urinary Tract Infection
Primary: Number of Participants With Elevated Cytokines (Levels of Pro-inflammatory) — 20; 20; 16 Participants
Phase 2 N=22 Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)
Infections, Bacterial
Primary: Area Under the Plasma Concentration-time Curve (AUC) From Zero (Pre-dose) Over the Dosing Interval (AUC[0-tau]) of Gepotidacin — 20236.2; 29313.8 Hours* nanogram per…
N/A N=773 Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.
Urinary Tract Infection Complicated · Urinary Tract Infection (cUTI) · Urinary Tract Infection (Diagnosis)
Primary: Favorable Clinical Outcomes (FCl) — 170; 132 Participants
Phase 2 N=134 Effectiveness of Preurodynamic With Posturodynamic Levofloxacin on the Incidence of UTI
Urinary Tract Infections
Primary: Number of Participant With Urinary Tract Infection — 12; 13 Participants
Phase 2 N=100 Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection
Urinary Tract Infection
Primary: Incidence of Urinary Tract Infection — 7; 13 participants
Phase 2 N=99 Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion
Urinary Tract Infections · Catheter Infection · Catheter-Related Infections
Primary: Number of Participants With a Catheter Associated Urinary Tract Infection (CAUTI) — 7; 6 Participants
Phase 1 N=80 Dosing Study of Cranberry Capsules for the Prevention of Bacteriuria in Nursing Home Residents
Bacteriuria
Primary: E.Coli Bacteriuria Plus Pyuria — 33; 29; 23; 25 urine cultures and urinalyses